id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-1653-0007,FDA,FDA-2014-E-1653,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2018-07-30T04:00:00Z,2018,7,2018-07-30T04:00:00Z,,2018-07-30T16:31:08Z,,0,0,0900006483586b4c
FDA-2014-E-1653-0006,FDA,FDA-2014-E-1653,"Determination of Regulatory Review Period for Purposes of Patent
Extension; SOLX SYSTEM",Notice,Determinations,2017-11-29T05:00:00Z,2017,11,2017-11-29T05:00:00Z,2018-01-30T04:59:59Z,2017-11-29T16:36:24Z,2017-25773,0,0,0900006482cbbd25
FDA-2014-E-1653-0005,FDA,FDA-2014-E-1653,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-06-05T04:00:00Z,2017,6,2017-06-05T04:00:00Z,,2017-06-05T19:30:08Z,,0,0,09000064826929ab
FDA-2014-E-1653-0004,FDA,FDA-2014-E-1653,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:37:41Z,,0,0,090000648243459f
FDA-2014-E-1653-0003,FDA,FDA-2014-E-1653,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-05T05:00:00Z,2015,11,2015-11-05T05:00:00Z,,2015-11-05T15:03:03Z,,0,0,0900006481d14460
FDA-2014-E-1653-0002,FDA,FDA-2014-E-1653,Patent Extension Application from Sunstein Kann Murphy & Timbers LLP on behalf of Haemonetics Corporation.,Other,Application,2014-10-20T04:00:00Z,2014,10,2014-10-20T04:00:00Z,,2014-10-20T13:07:23Z,,0,0,09000064818dd4fe
FDA-2014-E-1653-0001,FDA,FDA-2014-E-1653,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-10-20T04:00:00Z,2014,10,2014-10-20T04:00:00Z,,2014-10-20T13:06:30Z,,0,0,09000064818dd49f